Wis. Admin. Code Optometry Examining Board § Opt 6.02 - Definitions
In this chapter:
(1)
"Adverse drug reaction " means an adverse, physical or psychological reaction
experienced by a person resulting from diagnostic or therapeutic pharmaceutical
agents administered by an optometrist that occurs within 24 hours after the
drug is administered. An "adverse drug reaction " may be indicated by symptoms
that include any of the following:
(a) Red
eye.
(b) Painful eye.
(c) Decrease in vision.
(d) Pale or red swelling of the periocular or
periorbital tissues.
(e)
Nausea.
(f) Vomiting.
(g) Fainting.
(h) Mental confusion.
(i) Cessation of respiration.
(1e) " Approved institution " means
an institution approved by the board and accredited by a regional or
professional accrediting organization which is recognized by the Council for
Higher Education Accreditation or its successor or the federal department of
education, in accordance with ss.
449.17(1m)
(b) and
449.18(2)
(a) 2, Stats.
(1n) " Classroom hour " means a minimum of 50
minutes of lecture, group discussion, or laboratory. "Classroom hour " does not
include time spent working in a clinic other than as part of a laboratory
directly associated with a course in pharmacology.
(1s) " Course of study in pharmacology " means
a course of study completed in an approved institution after 1973 in general
and clinical pharmacology as it relates to optometry with the characteristics
described in s.
449.17(1m)
(b), Stats. For a course, such as a
continuing education course, that does not lead to a degree in optometry to
qualify as part of a course of study in pharmacology , the course must include
at least one examination on course content.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.